Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury
Alexander Wehr(Universitätsklinikum Aachen), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum), Christer Baeck(Universitätsklinikum Aachen), Florian Ulmer(Universitätsklinikum Aachen), Kanishka Hittatiya(University of Bonn), Tom Luedde(Düsseldorf University Hospital), Ulf P. Neumann(RWTH Aachen University), Nikolaus Gaßler(Ernst Abbe University of Applied Sciences Jena)
Cited by 79
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k